Focused Ultrasound Therapy to Augment Antigen Presentation and Immune-Specificity of Checkpoint Inhibitor Therapy With Pembrolizumab in Metastatic Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Advanced breast cancer
- Focus Pharmacodynamics
- Acronyms Breast-48
- 25 Sep 2017 Status changed from not yet recruiting to recruiting.
- 01 Sep 2017 Planned initiation date changed from 25 Aug 2017 to 19 Oct 2017.
- 04 Aug 2017 New trial record